Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 35,000 shares at $3.08 ($108K) on 2010-08-18, disclosed to the SEC on 2010-08-20.
Open-market sale of $108k AVNR by Senior VP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |